[{"NetIncomeLossConverted_1_Q2_USD":61813000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":128938851.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":133789977.0,"RevenuesConverted_2_Q2_USD":179052000.0,"RevenuesConverted_1_Q2_USD":177068000.0,"CommonStockSharesConverted_0_Q2_shares":130479975.0,"Assets_0_Q2_USD":1057581000.0,"EarningsPerShareBasic_1_Q2_USD":0.48,"StockholdersEquity_0_Q2_USD":737325000.0,"EarningsPerShareDiluted_1_Q2_USD":0.46,"EarningsPerShareDiluted_2_Q2_USD":-0.83,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":50529000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":128938851.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":130121943.0,"NetIncomeLossConverted_2_Q2_USD":-107098000.0,"CommonStockSharesOutstanding_0_Q2_shares":130479975.0,"EarningsPerShareBasic_2_Q2_USD":-0.83,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]